ADVERTISEMENT
Posted: May 7, 2024

UTIs: Common and treatable

OTCs Today

Urinary tract infections are among the most common bacterial infections, accounting for almost 9 mil-lion ambulatory care visits per year. 

Mary Warner

Read more
Posted: May 7, 2024

Biotin: Boon or bunk?

On the Shelf

Biotin has been at the top of supplement charts for years, promoted as being beneficial for shiny, thick hair; strong and fast-growing nails; and healthy, radiant skin. 

Mickie Cathers

Read more
Posted: Apr 7, 2024

Get ready: COVID-19 therapeutics transition to the commercial market

COVID-19 Antivirals

As pandemic uncertainty dissipates, COVID-19 therapeutics are transitioning from U.S. government- procured sources to the commercial market.

Clarissa Chan, PharmD

Read more
Posted: Apr 7, 2024

Barriers still present for OUD medications even after passage of MAT Act

Opioid Use Disorder

Even after passage of the Mainstreaming Addiction Treatment (MAT) Act in late 2023, patients still face difficulty gaining access to buprenorphine—the gold standard for treating patients with OUD.

Parth Patel, PharmD

Read more
Posted: Apr 7, 2024

Use of gabapentin in U.S. shows no sign of slowing

Gabapentin

Gabapenti.noid use has continued to climb in the United States, despite a lack of strong evidence for its effectiveness in pain management and other uses, according to a recent study published in the January 2024 issue of the Annals of Family Medicine.

Elizabeth Briand

Read more
First678911131415Last
Advertisement
Advertisement
Advertisement
Advertisement
ADVERTISEMENT